237 related articles for article (PubMed ID: 14706145)
21. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma.
King CA; Spellerberg MB; Zhu D; Rice J; Sahota SS; Thompsett AR; Hamblin TJ; Radl J; Stevenson FK
Nat Med; 1998 Nov; 4(11):1281-6. PubMed ID: 9809552
[TBL] [Abstract][Full Text] [Related]
22. Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model.
Rinaldi M; Fioretti D; Iurescia S; Signori E; Pierimarchi P; Seripa D; Tonon G; Fazio VM
Biochem Biophys Res Commun; 2008 May; 370(2):279-84. PubMed ID: 18364239
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
[TBL] [Abstract][Full Text] [Related]
24. Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice.
Ruffini PA; Os A; Dolcetti R; Tjønnfjord GE; Munthe LA; Bogen B
J Transl Med; 2014 Jul; 12():207. PubMed ID: 25059102
[TBL] [Abstract][Full Text] [Related]
25. Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses.
Forconi F; King CA; Sahota SS; Kennaway CK; Russell NH; Stevenson FK
Immunology; 2002 Sep; 107(1):39-45. PubMed ID: 12225361
[TBL] [Abstract][Full Text] [Related]
26. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
[TBL] [Abstract][Full Text] [Related]
27. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
[TBL] [Abstract][Full Text] [Related]
28. Production of phage-displayed anti-idiotypic antibody single chain variable fragments to MG7 monoclonal antibody directed against gastric carcinoma.
Fengtian H; Yongzhan N; Baojun C; Taidong Q; Zheyi H; Daiming F
Chin Med Sci J; 2002 Dec; 17(4):215-9. PubMed ID: 12901508
[TBL] [Abstract][Full Text] [Related]
29. Construction of a recombinant plasmid harbouring the glyceraldenyde-3-phosphate dehydrogenase gene of periodic Brugia malayi and observation on DNA immunity.
Fang Z; Tong H; Zhang S; Fang H; Lu S; Xu B
Indian J Med Microbiol; 2012; 30(2):193-7. PubMed ID: 22664436
[TBL] [Abstract][Full Text] [Related]
30. [The construction and immune response of fusion DNA vaccine CRT180/HPV6E7].
Zhao KJ; Cheng H; Xu Y; Zhu KJ; Chen ML; Zhang X; Song T; Wang Q; Chen DF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):573-7. PubMed ID: 17718414
[TBL] [Abstract][Full Text] [Related]
31. [Construction of eukaryotic recombinant plasmid of periodic Brugia malayi CPI gene and its immunity].
Zhang SN; Fang Z; Lu SJ; Wang H; Xu BS
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Dec; 29(6):434-8. PubMed ID: 24822343
[TBL] [Abstract][Full Text] [Related]
32. Idiotypic vaccine for treatment of human B-cell lymphoma. Construction of IgG variable regions from single malignant B cells.
Terness P; Welschof M; Moldenhauer G; Jung M; Moroder L; Kirchhoff F; Kipriyanov S; Little M; Opelz G
Hum Immunol; 1997; 56(1-2):17-27. PubMed ID: 9455490
[TBL] [Abstract][Full Text] [Related]
33. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
34. The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma.
Singh G; Parker S; Hobart P
Vaccine; 2002 Jan; 20(9-10):1400-11. PubMed ID: 11818159
[TBL] [Abstract][Full Text] [Related]
35. Generation and selection of immunized Fab phage display library against human B cell lymphoma.
Shen Y; Yang X; Dong N; Xie X; Bai X; Shi Y
Cell Res; 2007 Jul; 17(7):650-60. PubMed ID: 17621306
[TBL] [Abstract][Full Text] [Related]
36. T cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma.
Wen YJ; Lim SH
Eur J Immunol; 1997 Apr; 27(4):1043-7. PubMed ID: 9130662
[TBL] [Abstract][Full Text] [Related]
37. Gene conjugation of molecular adjuvant C3d3 to hCGbeta increased the anti-hCGbeta Th2 and humoral immune response in DNA immunization.
Wang XL; Zhao XR; Yu M; Yuan MM; Yao XY; Li DJ
J Gene Med; 2006 Apr; 8(4):498-505. PubMed ID: 16389614
[TBL] [Abstract][Full Text] [Related]
38. Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique.
Schlebusch H; Reinartz S; Kaiser R; Grünn U; Wagner U
Hybridoma; 1997 Feb; 16(1):47-52. PubMed ID: 9085128
[TBL] [Abstract][Full Text] [Related]
39. Intraclonal variability of VH genes in follicular lymphoma patients who have received anti-idiotypic immunotherapy.
Yáñez R; Barrios Y; Cabrera R; Díaz-Espada F
J Immunother; 2006; 29(1):61-6. PubMed ID: 16365601
[TBL] [Abstract][Full Text] [Related]
40. Escherichia coli-based production of a tumor idiotype antibody fragment--tetanus toxin fragment C fusion protein vaccine for B cell lymphoma.
Patel KG; Ng PP; Levy S; Levy R; Swartz JR
Protein Expr Purif; 2011 Jan; 75(1):15-20. PubMed ID: 20851769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
